Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure

ImmunityBio, Inc. (NK) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 DEF 14C Form DEF 14C - Other definitive information statements:
08/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/25/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/21/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
06/16/2023 4 LAUER REGAN J (Chief Accounting Officer) has filed a Form 4 on ImmunityBio, Inc.
Txns: Exercised 21,030 restricted stock units @ $0
06/15/2023 4 Selecky Christobel (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/15/2023 4 MAXWELL LINDA (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/15/2023 4 Cohen Cheryl (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/15/2023 4 Clark Wesley (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/15/2023 4 Brennan John Owen (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/15/2023 4 BLASZYK MICHAEL D (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Granted 158,263 options to buy @ $2.99, valued at $473.2k
06/05/2023 4 Clark Wesley (Director) has filed a Form 4 on ImmunityBio, Inc.
Txns: Bought 7,000 shares @ $2.91, valued at $20.4k
05/22/2023 SC 13D/A Cambridge Equities, LP reports a 77.3% stake in ImmunityBio, Inc.
05/16/2023 4 SOON-SHIONG PATRICK (See remarks) has filed a Form 4 on ImmunityBio, Inc.
Txns: Bought convertible notes @ $2.28, valued at $0
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "IMMUNITYBIO, INC. CONVERTIBLE PROMISSORY NOTE"
03/20/2023 8-K Quarterly results
03/01/2023 3/A Clark Wesley (Director) has filed a Form 3/A on ImmunityBio, Inc.
02/14/2023 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/13/2023 8-K Quarterly results
02/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/07/2023 4 Adcock Richard (CEO & President) has filed a Form 4 on ImmunityBio, Inc.
Txns: Paid exercise price by delivering 42,192 shares @ $4.33, valued at $182.7k
Exercised 83,333 restricted stock units @ $0
01/04/2023 4 Sachs David C. (CFO) has filed a Form 4 on ImmunityBio, Inc.
Txns: Exercised 7,598 restricted stock units @ $0
01/04/2023 4 Adcock Richard (CEO & President) has filed a Form 4 on ImmunityBio, Inc.
Txns: Paid exercise price by delivering 4,273 shares @ $5.07, valued at $21.7k
Exercised 8,620 restricted stock units @ $0
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obl...
Docs: "Placement Agency Agreement by and between the Company and Piper Sandler & Co.",
"Form of Common Stock Purchase Warrant",
"Legal Opinion of Wilson Sonsini Goodrich & Rosati, P.C",
"Securities Purchase Agreement",
"Promissory Note between the Company and Nant Capital, LLC",
"ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor"
12/12/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/12/2022 S-3MEF Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy